Pegasus Laboratories, Inc., announced that under its registered trademark PRN® Pharmacal, KBroVet® (potassium bromide chewable tablets) has received full approval from the U.S. Food and Drug Administration for the control of seizures associated with idiopathic epilepsy in dogs. The fully approved product labeling is expected to transition in the marketplace beginning … [Read more...]
PBI-Gordon Companies, Inc. calls on Petspan to cease, desist promotion, sale of compounded rapamycin (Sirolimus) for HCM in cats
PBI-Gordon Companies, Inc., the parent company of TriviumVet, which holds sole conditional new animal drug approval from the FDA for Felycin®-CA1 (sirolimus delayed-release tablets) under its affiliated brand company Pegasus, issued a cease-and-desist demand letter to Petspan for falsely promoting a compounded version of rapamycin (synonymous with sirolimus) for the treatment … [Read more...]